TUESDAY, Aug. 12, 2025 (HealthDay News) — A new vaccine aimed at a common cancer gene mutation could help stop aggressive ...

Radiation therapy may account for half of all new cancers among the growing population of childhood cancer survivors, according to a study published Aug. 11 in the Journal of Clinical Oncology. With ...

The "off-the-shelf" vaccine has also shown promising results for pancreatic cancer. Since the U.S. Preventive Services Task Force (USPSTF) changed its recommendation for when Americans at average risk ...

Yue Liao contributes to City of Hope article on wearable sensors and detecting or preventing long-term health risks ...

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back ...

A researcher at The University of Texas at Arlington is helping a leading national cancer center explore how wearable devices could help childhood cancer survivors avoid long-term health complications ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results ...

The FDA has granted accelerated approval to Hernexeos for the treatment of adults with unresectable or metastatic non-squamous NSCLC.

Early evidence of disease control was observed in the ongoing Phase 1 ACESOT-1051 trial, with three patients achieving stable disease in the 70 mg and 100 mg cohorts treated with the WEE1 inhibitor, A ...

Published scientific research fuels the breakthroughs that shape our world — but what happens when that research is totally fake?

MONTGOMERY, Texas — A Montgomery High School graduate is alive today thanks to his mother’s quick decision to take him to the emergency room after noticing what seemed like minor symptoms. That visit ...

TOKYO, JAPAN / ACCESS Newswire / August 12, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) ("Harrison Global" or the "Company"), a Japanese audio production, V-Tuber, entertainment, and voice acto ...